Overexpression of cyclin D1 in pancreatic β-cells in vivo results in islet hyperplasia without hypoglycemia

Diabetes

Volumn 54, Issue 3, 2005, Pages 712-719

  Zhang, Xiaoboo ^a   Gaspard, John P ^a   Mizukami, Yusuke ^a   Li, Jingnan ^a   Graeme Cook, Fiona ^a   Chung, Daniel C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; GLUCOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; EX VIVO STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HYPOGLYCEMIA; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL HYPERPLASIA; PANCREAS ISLET CELL TUMOR; PANCREAS ISLET TRANSPLANTATION; PHASE TRANSITION; PRIORITY JOURNAL;

AGING; ANIMALS; BLOOD GLUCOSE; CELL PROLIFERATION; CYCLIN D1; GENE EXPRESSION; GLUCOSE TOLERANCE TEST; HYPERPLASIA; HYPOGLYCEMIA; ISLETS OF LANGERHANS; MALE; MICE; MICE, TRANSGENIC;

EID: 14644422601     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.3.712     Document Type: Article

References (34)

1. Garcia-Ocana A, Vasavada R, Takane K, Cebrian A, Lopez-Talavera J, Stewart A: Using beta-cell growth factors to enhance human pancreatic islet transplantation. J Clin Endocrinol Metab 86:984-988, 2001
2. Vasavada RC, Cavaliere C, D'Ercole AJ, Dann P, Burtis WJ, Madlener AL, Zawalich K, Zawalich W, Philbrick W, Stewart AF: Overexpression of parathyroid hormone-related protein in the pancreatic islets of transgenic mice causes islet hyperplasia, hyperinsulinemia, and hypoglycemia. J Biol Chem 271:1200-1208, 1996
3. Garcia-Ocana A, Takane KK, Syed MA, Philbrick WM, Vasavada RC, Stewart AF: Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. J Biol Chem 275:1226-1232, 2000
4. Xu G, Stoffers DA, Habener JF, Bonner-Weir S: Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48:2270-2276, 1999
5. Smith FE, Rosen KM, Villa-Komaroff L, Weir GC, Bonner-Weir S: Enhanced insulin-like growth factor I gene expression in regenerating rat pancreas. Proc Natl Acad Sci U S A 88:6152-6156, 1991
6. Devedjian JC, George M, Casellas A, Pujol A, Visa J, Pelegrin M, Gros L, Bosch F: Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. J Clin Invest 105:731-740, 2000
7. Finegood D, Scaglia L, Bonner-Weir S: Dynamics of β-cell mass in the growing rat pancreas. Diabetes 44:249-256, 1995
8. Bonner-Weir S: Life death of the pancreatic beta cells. Trends Endocrinol Metab 11:375-378, 2000
9. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T: Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 7:480-484, 1994
10. Harvey M, Vogel H, Lee E, Bradley A, Donehower L: Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res 55:1146-1151, 1995
11. Sherr CJ: The Pezcoller Lecture: Cancer cell cycles revisited. Cancer Res 60:3689-3695, 2000
12. Levine AJ: p53, the cellular gatekeeper for growth division. Cell 88:323-331, 1997
13. Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M: Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet hyperplasia. Nat Genet 22:44-52, 1999
14. Tsutsui T, Hesabi B, Moons D, Pandolfi P, Hansel K, Koff A, Kiyokawa H: Targeted disruption of CDK4 delays cell cycle entry with enhanced p27Kip1 activity. Mol Cell Bio 19:7011-7019, 1999
15. Martin J, Hunt SL, Dubus P, Sotillo R, Nehme-Pelluard F, Magnuson MA, Parlow AF, Malumbres M, Ortega S, Barbacid M: Genetic rescue of Cdk4 null mice restores pancreatic beta-cell proliferation but not homeostatic cell number. Oncogene 22:5261-5269, 2003
16. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A: The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 20:501-534, 1999
17. Hsi E, Zukerberg L, Wang W, Arnold A: Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study. J Clin Endocrinol Metab 81:1736-1739, 1996
18. Chung DC, Brown SB, Graeme-Cook F, Warshaw AL, Jensen RT, Arnold A: Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. J Clin Endocrinol Metab 85:4373-4378, 2000
19. Kranenburg O, van der Eb AJ, Zantema A: Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J 15:46-54, 1996
20. Imanishi Y, Hosokawa Y, Yoshimoto K, Schipani E, Mallya S, Papanikolaou A, Kifor O, Tokura T, Sablosky M, Ledgard F, et al.: Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest 107:1093-102, 2001
21. Cozar-Castellano I, Takane KK, Bottino R, Balamurugan AN, Stewart AF: Induction of β-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D(1). Diabetes 53:149-159, 2004
22. Wang T, Cardiff R, Zukerberg L, Lees E, Arnold A, Schmidt EV: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369:669-671, 1994
23. Wang T, Bonner-Weir S, Oates PS, Chulak M, Simon B, Merlino G, Schmidt E, Brand S: Pancreatic gastrin stimulates islet differentiation of transforming growth factor α-induced ductular precursor cells. J Clin Invest 92:1349-1356, 1993
24. Zukerberg LR, Yang WI, Gadd M, Thor AD, Koerner FC, Schmidt EV, Arnold A: Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod Patho 8:560-567, 1995
25. O'Brien B, Harmon B, Cameron D, Allan D: Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. J Pathol 178:176-181, 1996
26. Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA: Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621-630, 1995
27. Zwijsen RM, Klompmaker R, Wientjens EB, Kristel PM, van der Burg B, Michalides RJ: Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol Cell Biol 16:2554-2560, 1996
28. Swenne I: The role of glucose in the in vitro regulation of cell cycle kinetics proliferation of fetal pancreatic B-cells. Diabetes 31:754-760, 1982
29. Coqueret O: Linking cyclins to transcriptional control. Gene 299:35-55, 2002
30. Ratineau C, Petry MW, Mutoh H, Leiter AB: Cyclin D1 represses the basic helix-loop-helix transcription factor, BETA2/NeuroD. J Biol Chem 277:8847-8853, 2002
31. Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB, Tsai MJ: Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes Dev 11:2323-2334, 1997
32. Robles AI, Larcher F, Whalin RB, Murillas R, Richie E, Gimenez-Conti IB, Jorcano JL, Conti CJ: Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. Proc Natl Acad Sci U S A 93:7634-7638, 1996
33. Nakagawa H, Wang T, Zukerberg L, Odze R, Togawa K, May G, Wilson J, Rustgi A: The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach. Oncogene 14:1185-1190, 1997
34. Deane NG, Parker MA, Aramandla R, Diehl L, Lee WJ, Washington MK, Nanney LB, Shyr Y, Beauchamp RD: Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Res 61:5389-5395, 2001